Menu
GeneBe

18-47841847-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP2

The NM_005901.6(SMAD2):c.1384C>T(p.Arg462Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,804 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R462H) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

SMAD2
NM_005901.6 missense

Scores

7
9
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 9.96
Variant links:
Genes affected
SMAD2 (HGNC:6768): (SMAD family member 2) The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PM1
In a domain MH2 (size 193) in uniprot entity SMAD2_HUMAN there are 18 pathogenic changes around while only 0 benign (100%) in NM_005901.6
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, SMAD2

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SMAD2NM_005901.6 linkuse as main transcriptc.1384C>T p.Arg462Cys missense_variant 11/11 ENST00000262160.11
SMAD2NM_001003652.4 linkuse as main transcriptc.1384C>T p.Arg462Cys missense_variant 11/11
SMAD2NM_001135937.3 linkuse as main transcriptc.1294C>T p.Arg432Cys missense_variant 10/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SMAD2ENST00000262160.11 linkuse as main transcriptc.1384C>T p.Arg462Cys missense_variant 11/111 NM_005901.6 Q15796-1
SMAD2ENST00000402690.6 linkuse as main transcriptc.1384C>T p.Arg462Cys missense_variant 11/111 Q15796-1
SMAD2ENST00000356825.8 linkuse as main transcriptc.1294C>T p.Arg432Cys missense_variant 10/101 P1Q15796-2
SMAD2ENST00000586040.5 linkuse as main transcriptc.1294C>T p.Arg432Cys missense_variant 9/95 P1Q15796-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461804
Hom.:
0
Cov.:
31
AF XY:
0.00000413
AC XY:
3
AN XY:
727202
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJun 05, 2023In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SMAD2 protein function. ClinVar contains an entry for this variant (Variation ID: 1521943). This variant has not been reported in the literature in individuals affected with SMAD2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 462 of the SMAD2 protein (p.Arg462Cys). -
Loeys-Dietz syndrome 6 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteJun 24, 2022Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3A. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with SMAD2-related connective tissue disorder (PMID: 29967133). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance. Rare examples of non-penetrance in Loeys-Dietz syndrome (LDS) have been documented, including somatic mosaicism (GeneReviews). (I) 0115 - Variants in this gene are known to have variable expressivity. Intrafamilial variability has been reported in LDS (GeneReviews). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to cysteine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v3) (1 heterozygote, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0601 - Variant is located in the well-established functional MH2 domain (PMID: 29967133). Mutagenesis studies have shown that Arg-462 is important for specific recognition and phosphorylation of the C-terminal serine residues of Smad2 by the type I TGFbeta receptor (PMID: 15210694). (SP) 0710 - Another missense variant comparable to the one identified in this case has inconclusive previous evidence for pathogenicity. The p.(Arg462His) variant has been reported as a VUS in ClinVar. (I) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1205 - This variant has been shown to be maternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Pathogenic
0.37
Cadd
Pathogenic
33
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D;D;.;.
Eigen
Pathogenic
0.70
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Pathogenic
1.0
D
M_CAP
Uncertain
0.11
D
MetaRNN
Uncertain
0.51
D;D;D;D
MetaSVM
Uncertain
0.65
D
MutationAssessor
Uncertain
2.1
M;M;.;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.79
T
PROVEAN
Benign
-2.1
N;N;N;.
REVEL
Pathogenic
0.71
Sift
Uncertain
0.0020
D;D;D;.
Sift4G
Uncertain
0.0030
D;D;D;D
Polyphen
0.99
D;D;D;D
Vest4
0.53
MutPred
0.37
Gain of catalytic residue at S464 (P = 0.0122);Gain of catalytic residue at S464 (P = 0.0122);.;.;
MVP
0.97
MPC
1.7
ClinPred
0.85
D
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.78
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr18-45368218; COSMIC: COSV51004391; COSMIC: COSV51004391; API